Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Organization and Description of the Business (Details Narrative)

Organization and Description of the Business (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 14, 2023	Feb. 09, 2023	Feb. 03, 2023	Mar. 23, 2022	Aug. 20, 2021	Jan. 31, 2023	Mar. 25, 2023	Dec. 31, 2022	Dec. 31, 2021	Apr. 12, 2023
Proceeds from issuance of stock								$ 6,400,000
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)								7,268,143
In Process Research and Development [Member]
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)								$ 7,300,000
Consulting Agreement [Member] \| Spartan Capital Securites LLC [Member] \| Forecast [Member]
Warrants issued to purchase common stock										3,160,130
Warrants exercise price										$ 1.02
Warrants term										3 years
Sales Agreement [Member]
Shares issued during period									21,597
Price per share									$ 8.33
Proceeds from issuance of stock									$ 174,000
Transaction costs, percentage					3.00%
Sales Agreement [Member] \| Maximum [Member]
Maximum number of shares to be sold at the market offering					$ 30,000,000.0
Purchase Agreement [Member] \| Lincoln Park Capital Fund LLC [Member]
Reimbursement fees				$ 25,000
Shares issued in connection with the Purchase Agreement with Lincoln Park, shares				123,609
Number of common stock issued on commitment fees, value				$ 450,000
Purchase Agreement [Member] \| Lincoln Park Capital Fund LLC [Member] \| Maximum [Member]
Maximum commitment to purchase common stock value				$ 15,000,000.0
Subsequent Event [Member]
Shares issued during period							8,432,192
Proceeds from issuance of stock							$ 7,000,000.0
Subsequent Event [Member] \| Securities Purchase Agreement [Member] \| Registered Direct Offering [Member] \| Spartan Capital Securites LLC [Member]
Proceeds from issuance of stock	$ 5,700,000
Subsequent Event [Member] \| Securities Purchase Agreement [Member] \| Registered Direct Offering [Member] \| Accredited Investor [Member]
Gross proceeds from issuance of stock	$ 6,300,000
Shares issued during period	7,812,544
Price per share	$ 0.80
Agreement conditions		The Purchase Agreement provides that, subject to certain exceptions, until the earlier of (i) 90 days after the closing of the Offering or (ii) the trading day following the date that our common stock’s closing price exceeds $2.00 for a period of 10 consecutive trading days neither we nor our subsidiary will issue or enter into any agreement to issue or announce the issuance or proposed issuance of any shares of common stock or common stock equivalents.
Proceeds from issuance of stock	$ 5,700,000
Subsequent Event [Member] \| Securities Purchase Agreement [Member] \| Registered Direct Offering [Member] \| Placement Agent [Member]
Transaction costs, percentage		8.00%
Reimbursement fees		$ 60,000
Subsequent Event [Member] \| ATM Offering [Member]
Shares issued during period			569,648
Proceeds from issuance of stock			$ 672,393
Subsequent Event [Member] \| Purchase Agreement [Member] \| Lincoln Park Capital Fund LLC [Member]
Shares issued during period						50,000
Price per share						$ 1.08
Proceeds from issuance of stock						$ 54,000